Compare MITT & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MITT | MASS |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.7M | 226.6M |
| IPO Year | N/A | 2020 |
| Metric | MITT | MASS |
|---|---|---|
| Price | $7.44 | $5.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | $9.25 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 325.1K | 275.6K |
| Earning Date | 05-05-2026 | 03-03-2026 |
| Dividend Yield | ★ 12.60% | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | $4.09 | $19.44 |
| Revenue Next Year | $4.69 | $18.63 |
| P/E Ratio | ★ $9.34 | $10.70 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.63 | $3.55 |
| 52 Week High | $9.27 | $9.34 |
| Indicator | MITT | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 38.78 |
| Support Level | $7.03 | $5.38 |
| Resistance Level | $7.86 | $6.09 |
| Average True Range (ATR) | 0.25 | 0.29 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 23.72 | 12.20 |
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. The company focuses on its investment activities on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.